SCHEMBL5758618

SCHEMBL5758618

CC(Sc1nnc(-c2ccccn2)n1C)c1noc(-c2cccc(F)c2)n1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 8/20 0.53
RAB9A P51151 9/20 0.51
NPC1 O15118 8/20 0.51
SMN1; SMN2 Q16637 4/20 0.44
ALDH1A1 P00352 2/20 0.42
MAPT P10636 2/20 0.41
DCTPP1 Q9H773 1/20 0.41
KCNH2 Q12809 3/20 0.40
DRD3 P35462 2/20 0.40
MAPK1 P28482 1/20 0.39
PKM P14618 2/20 0.39
MITF O75030 1/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
DRD2 P14416 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1544309 0.86 KCNH2 (0.53) GRM5RAB9ANPC1ALDH1A1KCNH2
SCHEMBL5760939 0.78 GRM5 (0.53) GRM5RAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL1543652 0.76 KCNH2 (0.55) GRM5RAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL1544676 0.75 TP53 (0.48) GRM5RAB9ANPC1KCNH2TP53
SCHEMBL1544620 0.75 KCNH2 (0.68) GRM5RAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL1544056 0.74 KCNH2 (0.51) GRM5RAB9ANPC1MAPTKCNH2
SCHEMBL4945927 0.73 RAB9A (0.48) GRM5RAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL1544356 0.73 KCNH2 (0.54) GRM5RAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL1543822 0.72 S1PR1 (0.47) RAB9ANPC1SMN1; SMN2ALDH1A1KCNH2
SCHEMBL1544947 0.72 KDM4E (0.46) RAB9ANPC1SMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1723144-A1 ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2006-11-22 EP disclosed
WO-2006014185-A1 ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2006-02-09 WO disclosed